Delivery Order SPE2DB20D3303-SPE2DB25FA1WK
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Synvisc-One syringes (6mL) with a ceiling value of $3,885.12 under a firm fixed-price contract type. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 22, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $19,398.41 on July 29, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract requires no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,370.86 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for knee osteoarthritis treatment. This non-set-aside, competitively awarded contract is scheduled for completion by July 21, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used in orthopedic and rheumatological applications. The contract, valued at $14,689.32, is a firm fixed price delivery order with an ultimate completion date of August 1, 2025. This award represents a non-set-aside, competitively awarded contract supporting the federal medical procurement needs of military and veteran healthcare systems....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of Synvisc-One syringes, a specialty pharmaceutical product, with a ceiling value of $1,644.56 and a performance period through March 13, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation, for the supply of Synvisc-One syringe 6 ml. The contract has a potential value of $1,605.08 and a completion date of March 1, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA with a potential value of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,251.76 firm fixed-price delivery order is for SYNVISC-ONE SYRINGE 6ML, a medical product, with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency awarded a $6,529 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of six milliliter syringes of Synvisc-One. The single syringe order is to be delivered to the prime contractor's facility in Conshohocken, Pennsylvania by July 11, 2023 under contract number 4561454979. Amerisourcebergen will fulfill the Defense Logistics Agency's need for this medical device as part of its role on an indefinite-delivery/indefinite-quantity...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $3,373.43, is for the supply of SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024 and is a firm-fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $2,846.63 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561342753 SYNVISC-ONE SYRINGE 6ML. The single award was issued against an existing Prime Vendor contract vehicle to provide pharmaceutical products and services to DOD and other federal customers. Amerisourcebergen will deliver the specified medical device to a facility in Conshohocken, Pennsylvania between June 26-27, 2023. As the DLA supports the procurement...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1WKDelivery Order
The Defense Logistics Agency awarded a $1,729.05 delivery order to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a pharmaceutical product used in joint pain management. This firm fixed price contract, issued on July 29, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this award, indicating it was competitively procured under open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order, with an ultimate completion date of July 30, 2025, represents one of numerous delivery orders issued under this prime vehicle to fulfill ongoing federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/29/25 |